MARKET

MYGN

MYGN

Myriad Genetics
NASDAQ
18.50
0.00
0.00%
Opening 12:54 04/22 EDT
OPEN
18.76
PREV CLOSE
18.50
HIGH
18.76
LOW
18.43
VOLUME
105.62K
TURNOVER
0
52 WEEK HIGH
24.21
52 WEEK LOW
13.82
MARKET CAP
1.67B
P/E (TTM)
-5.8176
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at MYGN last week (0415-0419)?
Weekly Report · 7h ago
MYRIAD GENETICS INC <MYGN.O>: BOFA GLOBAL RESEARCH CUTS PRICE OBJECTIVE TO $18 FROM $22
Reuters · 5d ago
MYRIAD GENETICS INC <MYGN.O>: TD COWEN CUTS TARGET PRICE TO $23 FROM $26
Reuters · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
The Nasdaq and the S&P 500 were muted on Tuesday as higher Treasury yields pressured equities. The blue-chip Dow bucked the trend on robust results from health insurance heavyweight UnitedHealth. The Dow Jones Industrial Average was up 0.13% at 37,783.35. UnitedHealth Group's quarterly results beat expectations.
Reuters · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals
Dow Jones Industrial Average up 0.13% after upbeat results from health insurer UnitedHealth. Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals among top stocks on the move. Higher Treasury yields and conflict in the Middle East keep investors on edge.
Reuters · 6d ago
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
Study shows exceptional positive predictive value for 22q11.2 microdeletion screening using Myriad’s prenatal cell-free DNA screen, Prequel. Myriad Genetics is a leader in genetic testing and precision medicine. The study was published in Prenatal Diagnosis.
Barchart · 6d ago
BUZZ-U.S. STOCKS ON THE MOVE-Snap One, Encore Wire, Centene
The Dow Jones Industrial Average was down 0.45% on Monday. Goldman Sachs boosted by robust gains. Snap One, Encore Wire, Centene were among the top stocks on the NYSE. The S&P 500 and Nasdaq Composite both fell on the day. U.S. Retail sales were stronger than expected.
Reuters · 6d ago
BUZZ-U.S. STOCKS ON THE MOVE-Cisco Systems, Inspired Entertainment, Spirit Airlines
Dow Jones Industrial Average was up 0.36% at 38,119.77. Goldman Sachs boosted by robust gains. Top three S&P 500 percentage gainers: M&T Bank, Centene, Snap One. Apple down 0.6% after falling in premarket trading.
Reuters · 04/15 16:13
More
About MYGN
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, EndoPredict, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight.

Webull offers Myriad Genetics, Inc. stock information, including NASDAQ: MYGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MYGN stock methods without spending real money on the virtual paper trading platform.